January 17, 2007 – Lilly published data showing that Gemzar doubled survival time in patients with pancreatic cancer after pancrease removal; Shire received FDA approval for Lialda, an ulcerative colitis drug; GlaxoSmithKline was given a $63 million contract to develop pandemic flu vaccines; Geron published data showing that a stem cell drug stimulates neurons growth following spinal cord injury; MDS Nordion started treating liver cancer patients with TheraSphere; GenVec will conduct a clinical trial of its experimental vaccine for malaria; Cerus received approval in France for plasma treated with the Intercept Blood System; Genaera detailed the method of action of a new appetite suppression drug; and Cepheid entered a sepsis collaboration with bioMerieux of France. The Centient Biotech 200™ rose 5 points to clear 4100 for the first time. More details...
